Wednesday, October 30, 2013

Clinical studies and research boost local economies around the United States

Clinical research is one of the most important parts of getting a drug to market - and relying on local markets are one of the best ways to find patients.  Nebraska, Montana and Kansas are three states who see the value in pushing clinical research on the local level and also look the the economic benefits that come along with supporting the life saving research.  Many of the states in this article focus on clinical trials for medications that will treat the illnesses that patients suffer from most often: asthma, diabetes, mental illness, cancer, heart disease and stroke.

In Nebraska, the state has hosted sites for 486 trials, roughly 25% of all clinical trials that have taken place in the United States since 1999.  The Lincoln Journal Star shares that the state has focused on developing top facilities to attract the clinical trial researchers.  They also note that the trials have brought over 10,000 jobs to the state and $2.5 billion in revenue.

Montana has seen many of the same benefits of focusing on bringing clinical trials to their state.  They've seen over 800 clinical trials conducted in their state, many conduced in the facilities: Billings Clinic, Frontier Cancer Center and Blood Institute, Montana Health Research Institute and Clinical Research Group of Montana. According to the Billings Gazette, there are still over 200 trials going on in the state.  Sharon Peterson of Billings is executive director of the Montana BioScience Alliance, author of the article, points out that beyond clinical trials they are making efforts to find safer and more effective treatments and working to find ways of early detection and prevention of diseases.  Although the sites listed above are the main focuses on clinical trials, they have sites contracted throughout the state, so the economic value is spread over the large state.

In Kansas, voters get to make their choice on funding of medical research.  The new county sales tax would raise $800 million to fund medial research at the University of Missouri - Kansas City who would team up with Jackson County Institute for Translational Medicine.  According to the Kansas City Star, the sales tax would go towards the salaries of scientists to do the research to come up with the life saving drugs to improve human health.  They hope to fill in the gap of initial research for drug companies as their spending on R&D has dwindled over the past years.  Ir  is estimated that this effort would raise $607 million and create over 230 jobs for the community.  The county would see 30% of the profits of any drugs, devices or efforts that went to market as a result of their efforts.

No comments: